Literature DB >> 19107570

A novel mutation in NDUFS4 causes Leigh syndrome in an Ashkenazi Jewish family.

S L Anderson1, W K Chung, J Frezzo, J C Papp, J Ekstein, S DiMauro, B Y Rubin.   

Abstract

Leigh syndrome is a neurodegenerative disorder of infancy or childhood generally due to mutations in nuclear or mitochondrial genes involved in mitochondrial energy metabolism. We performed linkage analysis in an Ashkenazi Jewish (AJ) family without consanguinity with three affected children. Linkage to microsatellite markers D5S1969 and D5S407 led to evaluation of the complex I gene NDUFS4, in which we identified a novel homozygous c.462delA mutation that disrupts the reading frame. The resulting protein lacks a cAMP-dependent protein kinase phosphorylation site required for activation of mitochondrial respiratory chain complex I. In a random sample of 5000 healthy AJ individuals, the carrier frequency of the NDUFS4 mutation c.462delA was 1 in 1000, suggesting that it should be considered in all AJ patients with Leigh syndrome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19107570     DOI: 10.1007/s10545-008-1049-9

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  23 in total

1.  The Dor Yeshorim story: community-based carrier screening for Tay-Sachs disease.

Authors:  J Ekstein; H Katzenstein
Journal:  Adv Genet       Date:  2001       Impact factor: 1.944

Review 2.  Human mitochondrial complex I in health and disease.

Authors:  J Smeitink; L van den Heuvel
Journal:  Am J Hum Genet       Date:  1999-06       Impact factor: 11.025

3.  Molecular basis of lipoamide dehydrogenase deficiency in Ashkenazi Jews.

Authors:  A Shaag; A Saada; I Berger; H Mandel; A Joseph; A Feigenbaum; O N Elpeleg
Journal:  Am J Med Genet       Date:  1999-01-15

4.  Demonstration of a new pathogenic mutation in human complex I deficiency: a 5-bp duplication in the nuclear gene encoding the 18-kD (AQDQ) subunit.

Authors:  L van den Heuvel; W Ruitenbeek; R Smeets; Z Gelman-Kohan; O Elpeleg; J Loeffen; F Trijbels; E Mariman; D de Bruijn; J Smeitink
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

Review 5.  Isolated complex I deficiency in children: clinical, biochemical and genetic aspects.

Authors:  J L Loeffen; J A Smeitink; J M Trijbels; A J Janssen; R H Triepels; R C Sengers; L P van den Heuvel
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

6.  Mutation in the NDUFS4 gene of complex I abolishes cAMP-dependent activation of the complex in a child with fatal neurological syndrome.

Authors:  S Papa; S Scacco; A M Sardanelli; R Vergari; F Papa; S Budde; L van den Heuvel; J Smeitink
Journal:  FEBS Lett       Date:  2001-02-02       Impact factor: 4.124

7.  Leigh syndrome associated with a mutation in the NDUFS7 (PSST) nuclear encoded subunit of complex I.

Authors:  R H Triepels; L P van den Heuvel; J L Loeffen; C A Buskens; R J Smeets; M E Rubio Gozalbo; S M Budde; E C Mariman; F A Wijburg; P G Barth; J M Trijbels; J A Smeitink
Journal:  Ann Neurol       Date:  1999-06       Impact factor: 10.422

8.  Mutant NDUFV1 subunit of mitochondrial complex I causes leukodystrophy and myoclonic epilepsy.

Authors:  M Schuelke; J Smeitink; E Mariman; J Loeffen; B Plecko; F Trijbels; S Stöckler-Ipsiroglu; L van den Heuvel
Journal:  Nat Genet       Date:  1999-03       Impact factor: 38.330

9.  A nonsense mutation in the NDUFS4 gene encoding the 18 kDa (AQDQ) subunit of complex I abolishes assembly and activity of the complex in a patient with Leigh-like syndrome.

Authors:  V Petruzzella; R Vergari; I Puzziferri; D Boffoli; E Lamantea; M Zeviani; S Papa
Journal:  Hum Mol Genet       Date:  2001-03-01       Impact factor: 6.150

10.  Mutant NDUFV2 subunit of mitochondrial complex I causes early onset hypertrophic cardiomyopathy and encephalopathy.

Authors:  Paule Bénit; Réjane Beugnot; Dominique Chretien; Irina Giurgea; Pascale De Lonlay-Debeney; Jean-Paul Issartel; Marisol Corral-Debrinski; Stefan Kerscher; Pierre Rustin; Agnès Rötig; Arnold Munnich
Journal:  Hum Mutat       Date:  2003-06       Impact factor: 4.878

View more
  13 in total

Review 1.  Mitochondrial Diseases Part I: mouse models of OXPHOS deficiencies caused by defects in respiratory complex subunits or assembly factors.

Authors:  Alessandra Torraco; Susana Peralta; Luisa Iommarini; Francisca Diaz
Journal:  Mitochondrion       Date:  2015-02-04       Impact factor: 4.160

2.  Fatal breathing dysfunction in a mouse model of Leigh syndrome.

Authors:  Albert Quintana; Sebastien Zanella; Henner Koch; Shane E Kruse; Donghoon Lee; Jan M Ramirez; Richard D Palmiter
Journal:  J Clin Invest       Date:  2012-06-01       Impact factor: 14.808

3.  High-throughput, pooled sequencing identifies mutations in NUBPL and FOXRED1 in human complex I deficiency.

Authors:  Sarah E Calvo; Elena J Tucker; Alison G Compton; Denise M Kirby; Gabriel Crawford; Noel P Burtt; Manuel Rivas; Candace Guiducci; Damien L Bruno; Olga A Goldberger; Michelle C Redman; Esko Wiltshire; Callum J Wilson; David Altshuler; Stacey B Gabriel; Mark J Daly; David R Thorburn; Vamsi K Mootha
Journal:  Nat Genet       Date:  2010-09-05       Impact factor: 38.330

Review 4.  Mouse models for nuclear DNA-encoded mitochondrial complex I deficiency.

Authors:  Saskia Koene; Peter H G M Willems; Peggy Roestenberg; Werner J H Koopman; Jan A M Smeitink
Journal:  J Inherit Metab Dis       Date:  2010-01-27       Impact factor: 4.982

Review 5.  The genetics of Leigh syndrome and its implications for clinical practice and risk management.

Authors:  Ilene S Ruhoy; Russell P Saneto
Journal:  Appl Clin Genet       Date:  2014-11-13

6.  Mitochondrial complex I deficiency leads to the retardation of early embryonic development in Ndufs4 knockout mice.

Authors:  Mei Wang; Ya-Ping Huang; Han Wu; Ke Song; Cong Wan; A-Ni Chi; Ya-Mei Xiao; Xiao-Yang Zhao
Journal:  PeerJ       Date:  2017-05-18       Impact factor: 2.984

7.  AAV9-based gene therapy partially ameliorates the clinical phenotype of a mouse model of Leigh syndrome.

Authors:  I Di Meo; S Marchet; C Lamperti; M Zeviani; C Viscomi
Journal:  Gene Ther       Date:  2017-07-27       Impact factor: 5.250

8.  Dose-dependent effects of mTOR inhibition on weight and mitochondrial disease in mice.

Authors:  Simon C Johnson; Melana E Yanos; Alessandro Bitto; Anthony Castanza; Arni Gagnidze; Brenda Gonzalez; Kanav Gupta; Jessica Hui; Conner Jarvie; Brittany M Johnson; Nicolas Letexier; Lanny McCanta; Maya Sangesland; Oliver Tamis; Lauren Uhde; Alex Van Den Ende; Peter S Rabinovitch; Yousin Suh; Matt Kaeberlein
Journal:  Front Genet       Date:  2015-07-22       Impact factor: 4.599

9.  Arabidopsis thaliana alternative dehydrogenases: a potential therapy for mitochondrial complex I deficiency? Perspectives and pitfalls.

Authors:  Alessia Catania; Arcangela Iuso; Juliette Bouchereau; Laura S Kremer; Marina Paviolo; Caterina Terrile; Paule Bénit; Allan G Rasmusson; Thomas Schwarzmayr; Valeria Tiranti; Pierre Rustin; Malgorzata Rak; Holger Prokisch; Manuel Schiff
Journal:  Orphanet J Rare Dis       Date:  2019-10-29       Impact factor: 4.123

Review 10.  Blackout in the powerhouse: clinical phenotypes associated with defects in the assembly of OXPHOS complexes and the mitoribosome.

Authors:  Daniella H Hock; David R L Robinson; David A Stroud
Journal:  Biochem J       Date:  2020-11-13       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.